Anette Breindl

Albany

Senior Science Editor at BioWorld

Managing Editor at BioWorld Science

Featured in: Favicon

bioworld.com

Articles

Pandemic potential is plentiful, but the next bug’s specifics are known unknown

1 week ago | bioworld.com | Anette Breindl

Pandemic potential is plentiful, but the next bug’s specifics are known unknownCompared to other forms of prevention, a unique issue for pandemic preparedness is that it is forever unclear what pathogen, exactly, the world needs to be prepared for. There are an estimated 300,000 viruses that infect mammals; add in birds, and the estimate grows to more than half a million. Some of those viruses are much greater threats than others. BioWorld Asia Science Conferences Infection Respiratory
Pandemic potential is plentiful, but the next bug’s specifics are known unknown

2 weeks ago | bioworld.com | Anette Breindl

InfectionPandemic potential is plentiful, but the next bug’s specifics are known unknownCompared to other forms of prevention, a unique issue for pandemic preparedness is that it is forever unclear what pathogen, exactly, the world needs to be prepared for. There are an estimated 300,000 viruses that infect mammals; add in birds, and the estimate grows to more than half a million. Some of those viruses are much greater threats than others. BioWorld Science Conferences Infection Respiratory
With ‘wholesale assault’ on research, bipartisan alarm at institutional failure

2 weeks ago | bioworld.com | Anette Breindl

With ‘wholesale assault’ on research, bipartisan alarm at institutional failureBiomedical research seems like it should be the ultimate bipartisan issue. But under the Trump administration, unless and until Congress regains its will to make use of its constitutional powers, bipartisan support for research seems to be a thing of the past. BioWorld MedTech Analysis and data insight Regulatory Cancer Infection U.S. NIH Policy
With ‘wholesale assault’ on research, bipartisan alarm at institutional failure

2 weeks ago | bioworld.com | Anette Breindl

PolicyWith ‘wholesale assault’ on research, bipartisan alarm at institutional failureBiomedical research seems like it should be the ultimate bipartisan issue. But under the Trump administration, unless and until Congress regains its will to make use of its constitutional powers, bipartisan support for research seems to be a thing of the past.
With ‘wholesale assault’ on research, bipartisan alarm at institutional failure

3 weeks ago | bioworld.com | Anette Breindl

With ‘wholesale assault’ on research, bipartisan alarm at institutional failureBiomedical research seems like it should be the ultimate bipartisan issue. But under the Trump administration, unless and until Congress regains its will to make use of its constitutional powers, bipartisan support for research seems to be a thing of the past.
Long COVID science is progressing, though therapies have not yet followed

1 month ago | bioworld.com | Anette Breindl

In 2020, the Conference on Retroviruses and Opportunistic Infections (CROI) was the first scientific conference to move from in-person to virtual due to the COVID-19 pandemic. On the fifth anniversary of the virtual conference, and the pandemic, some of those earliest COVID-19 patients have still not recovered. “We’re five years into the epidemic.
In HIV, draining the reservoir means understanding the brain

1 month ago | bioworld.com | Anette Breindl

HIV/AIDSIn HIV, draining the reservoir means understanding the brainThe availability of effective antiretroviral therapy has lowered the risk, and the severity, of neural sequelae of HIV infection. “Early in the HIV pandemic, approximately 15% of people with HIV had dementia and or encephalitis,” Howard Fox told his audience. “Fortunately, with treatment, the prevalence of these severe disorders has been greatly lowered.
Long COVID science is progressing, though therapies have not yet followed

1 month ago | bioworld.com | Anette Breindl

Home » Long COVID science is progressing, though therapies have not yet followed On March 1, 2025, former NIH director Francis Collins’ announced that he had fully resigned from the NIH, where he continued to lead a laboratory after his... BioWorld briefs for March 12, 2025. BioWorld MedTech briefs for March 12, 2025 At the 2025 meeting of the Conference on Retroviruses and Opportunistic Infections (CROI) it was the best of times, it was the worst of times. On the first full...
At CROI, HIV cure trials raise hopes for broader applicability

1 month ago | bioworld.com | Anette Breindl

NIH changes set industry up for workforce, ideas droughtOn March 1, 2025, former NIH director Francis Collins’ announced that he had fully resigned from the NIH, where he continued to lead a laboratory after his...
At CROI, HIV cure trials raise hopes for broader applicability

1 month ago | bioworld.com | Anette Breindl

HIV/AIDSAt CROI, HIV cure trials raise hopes for broader applicabilityAt the 2025 meeting of the Conference on Retroviruses and Opportunistic Infections (CROI) it was the best of times, it was the worst of times. On the first full day of the conference, reports from the first HIV cure trial conducted in Africa, the RIO trial and others showed that perhaps, a broadly useful cure is on the horizon.